Gene Therapy, Drilling Contractor Raise $101.5M In Debuts
A gene therapy business and a drilling contractor began trading publicly on Wednesday, garnering a combined $101.5 million in initial public offerings led by Goodwin Procter and Skadden Arps Slate Meagher...To view the full article, register now.
Already a subscriber? Click here to view full article